Involvement of cyclin-dependent kinase activities in CD437-induced apoptosis

Experimental Cell Research

Volumn 252, Issue 2, 1999, Pages 332-341

  Hsu, Shih Lan ^a   Yin, Sui Chu ^a   Liu, Mei Chun ^a   Reichert, Uwe ^b   Ho, William L ^a  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b Galderma R and D   (France)

Author keywords

Apoptosis; CD437; Cyclin A; Cyclin B; Iso olomoucine; Olomoucine; Roscovitine

Indexed keywords

6 [3 (1 ADAMANTYL) 4 HYDROXYPHENYL] 2 NAPHTHOIC ACID; CYCLIN A; CYCLIN B; CYCLIN DEPENDENT KINASE; OLOMOUCINE; PROTEIN BCL 2; PROTEIN BCL X; PROTEIN P21; PROTEIN P53; RETINOID; ROSCOVITINE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CYCLE S PHASE; CELL STRAIN HEPG2; CHROMATIN CONDENSATION; CONTROLLED STUDY; DNA DEGRADATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0033231483     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1999.4625     Document Type: Article

References (40)

1. Smith M., Parkinson D., Cheson B., Friedman M. Retinoids in cancer therapy. J. Clin. Oncol. 10:1992;839-864.
2. Lotan R. Retinoids and apoptosis: Implications for cancer chemoprevention and therapy. J. Natl. Cancer Inst. 87:1995;1655-1657.
3. Lotan R. Retinoids in cancer chemoprevention. FASEB J. 10:1996;1031-1039.
4. Mangelsdorf D. J. Vitamin A receptors. Nutr. Rev. 52:1994;S32-S44.
5. Giguere V. Retinoic acid receptors and cellular retinoid binding proteins: Complex interplay in retinoid signaling. Endocr. Rev. 15:1994;61-79.
6. Chambon P. A decsade of molecular biology of retinoic acid receptors. FASEB J. 10:1996;940-954.
7. Schadendorf D., Kern M. A., Artuc M., Pahl H. L., Rosenbach T., Fichtner I., Nurnberg W., Stuting S., Stebut E. V., Worm M., Makki A., Jurgovsky K., Kolde G., Henz B. M. Treatment of melanoma cells with synthetic retinoid CD437 induces apoptosis via activation of AP-1 in vitro, and causes growth inhibition in xenografts in vivo. J. Cell Biol. 135:1996;1889-1898.
8. Sun S-Y., Yue P., Shroot B., Hong W. K., Lotan R. Induction of apoptosis in human non-small cell lung carcinoma cells by the novel synthetic retinoid CD437. J. Cell. Physiol. 173:1997;279-284.
9. Majno G., Joris I. Apoptosis, oncosis, and necrosis - An overview of cell death. Am. J. Pathol. 146:1995;3-19.
10. Schwartzman R. A., Cidlowski J. A. Apootosis: The biochemistry and molecular biology of programmed cell death. Endocr. Rev. 14:1993;133-151.
11. Collins M. K. L., Rivas A. L. The control of apoptosis in mammalian cells. Trends Biochem. Sci. 18:1993;307-309.
12. Meyn R. E., Milas L., Stephens L. C. Programmed cell death in normal development and disease. Cancer Bull. 46:1994;120-129.
13. Green D. R., Bissonnette R. P., Cotter T. G. Apoptosis and cancer. Principles Practice Oncol. 8:1994;1-14.
14. Widschwendter M., Daxenbichler G., Culig Z., Michel S., Zeimet A. G., Mortl M. G., Widschwendter A., Marth C. Activity of retinoic acid receptor-γ selectively binding retinoids alone and in combination with interferon-γ in breast cancer cell lines. Int. J. Cancer. 71:1997;497-504.
15. Hsu C. A., Rishi A. K., Xiao S-L., Gerald T. M., Dawson M. I., Schiffer C., Reichert U., Shroot B., Poirer G. C., Fontana J. A. Retinoid induced apoptosis in leukemia cells through a retinoic acid nuclear receptor-independent pathway. Blood. 89:1997;4470-4479.
16. Sun S-Y., Yue P., Dawwson M. I., Shroot B., Michel S., Lamph W. W., Heyman R. A., Teng M., Chandraratna R. A. S., Shudo K., Hong W. K., Lotan R. Differential effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human non-small cell lung carcinoma cells. Cancer. Res. 57:1997;4931-4939.
17. Sandstrom P., Buttke T. M. Autocrine production of extracellular catalase prevents apoptosis of the human CEM T-cell line in serum-free medium. Proc. Natl. Acad. Sci. USA. 90:1993;4708-4712.
18. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
19. Wang J., Chenivesse X., Henglein B., Brechot C. Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma. Nature. 343:1990;555-557.
20. cdc2. Cell. 58:1989;833-846.
21. Harper J. W., Adami G. R., Wei N., Keyomarsi K., Elledge S. J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 75:1993;805-816.
22. Hsu S. L., Wu W. S., Tyan Y. S., Chou C. K. Retinoic acid-induced apoptosis is prevented by serum albumin, and enhanced by Lipiodol in human hepatoma Hep3B cells. Cancer Lett. 129:1998;205-214.
23. Adams J. M., Cory S. The Bcl-2 protein family: Arbiters of cell survival. Science. 281:1998;1322-1326.
24. 1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells. Oncogene. 11:1995;493-504.
25. Rubin L. L., Philpott K. L., Brooks S. F. The cell cycle and cell death. Curr. Biol. 3:1993;391-394.
26. Elledge S. J., Richman R. R., Hall F. L., Williams R. T., Lodgson N., Harper J. W. CDK2 encodes a 33-kDa cyclin A-associated protein kinase and is expressed before CDC2 in the cell cycle. Proc. Natl. Acad. Sci. USA. 89:1992;2907-2911.
27. Vesely J., Havlicek L., Strand M., Blow J. J., Donella-Deana A., Pinna L., Letham D. S., Kato J-Y., Detivaud L., Leclerc S., Meijer L. Inhibition of cyclin-dependent kinases by purine analogues. Eur. J. Biochem. 224:1994;771-786.
28. De Azevedo W. F., Leclerc S., Meijer L., Havlicek L., Strand M., Kim S. H. Inhibition of cyclin-dependent kinases by purine analogues: Crystal structure of human Cdk2 complex with roscovitine. Eur. J. Biochem. 243:1997;518-526.
29. Mologni L., Ponzanelli I., Bresciani F., Sardiello G., Bergamaschi D., Gianni M., Reichert U., Rambaldi A., Terao M., Garattini E. The novel synthetic retinoid 6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) causes apoptosis in acute promyelocytic leukemia cells through rapid activation of caspases. Blood. 93:1999;1045-1061.
30. Agarwal M. L., Taylor W. R., Chernov M. V., Chernova O. B., Stark G. R. The p53 network. J. Biol. Chem. 273:1998;1-4.
31. Levine A. J. p53, the cellular gatekeeper for growth and division. Cell. 88:1997;323-331.
32. Boise L. H., Gonzales-Garcoa M., Postema C. E., Ding L., Lindsten T., Turka L. A., Mao, Nunez G., Thompson C. B. Bcl-X, a Bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell. 74:1993;597-608.
33. Adachi H., Preston G., Harvat B., Dawson M. I., Jetten A. M. Inhibition of cell proliferation and induction of apoptosis by the retinoid AHPN in human lung carcinoma cells. Am. J. Respir. Cell Mol. Biol. 18:1998;323-333.
34. Krust A., Kastner P., Petkovich M., Zelent A., Chambon P. A third human retinoic acid receptor, hRAR-γ Proc. Natl. Acad. Sci. USA. 86:1989;5310-5314.
35. cdc2 activation required for apoptosis. Science. 263:1994;1143-1145.
36. cdc2 coincident with taxol-induced apoptosis. Cell Growth Differ. 5:1994;1041-1050.
37. Harvey K. J., Blomquist J. F., Ucker D. S. Commitment and effector phases of the physiological cell death pathway elucidated with respect to Bcl-2, caspase, and cyclin-dependent kinase activities. Mol. Cell. Biol. 18:1998;2912-2922.
38. Shimizu T., O'Connor P. M., Kohn K. W., Pommier Y. Unscheduled activation of cyclin B1/cdc2 kinase in human promyelocytic leukemia cell line HL60 cells undergoing apoptosis induced by DNA damage. Cancer Res. 55:1995;228-231.
39. Wang Q., Worland P. J., Clark J. L., Carlson B. A., Sausville E. A. Apoptosis in 7-hydroxystaurospurine-treated T lymphoblasts correlates with activation of cyclin-dependent kinases 1 and 2. Cell Growth Differ. 6:1995;927-936.
40. Avis I., Mathias A., Unsworth E. J., Mitter M., Cuttitta F., Mulshine J. L., Jakowlew S. B. Analysis of small cell lung cancer cell growth inhibition by 13-cis-retinoic acid: Importance of bioavailability. Cell Growth Differ. 6:1995;485-492.